Neuropeptides and Migraine-A Useful Biological Marker?

Gallai V Sarchielli P Floridi A Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 1995;15:384–90

Goadsby PJ Edvinsson L Ekman R Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system. Ann Neurol 1988;23:193–6

Moskowitz MA Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307–11

Goadsby PJ The challenge of headache for the nineties. Curt Opin Neurol 1994;7:255–82

McCulloch J Uddman R Kingman TA Edvinsson L Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci (USA) 1986;83:1–5

Juul R Edvinsson L Gisvold SE Ekman R Brubakk AO Fredriksen TA Calcitonin gene-related peptide-L1 in subarachnoid haemorrhage in man. Signs of activation of the trigemino-cerebrovascular system? Br J Neurosurg 1990;4:171–80

Edvinsson L Brodin E Janson I Uddman R Neurokinin A in cerebral vessels: characterization, localization and effects in vitro. Reg Peptides 1988;20:181–97

Goadsby PJ Edvinsson L Ekman R Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183–7